As a multi-receptor agonist, Retatrutide simultaneously targets GLP-1, GIP, and glucagon receptors, enhancing weight loss, improving glucose regulation, and supporting lipid metabolism
Japanese journal of clinical medicine
Its frustrating, and its not your fault weight loss is more complicated than just calories in, calories out. Thats why weight loss medications like semaglutide and tirzepatide are changing the game
So from a primary care frontline clinicians perspective, what do you wish more primary care doctors knew about GLP-1 medications
Zone 1: $194,120 - $242,650 Zone 2: $185,680 - $232,100 Zone 3: $168,800 - $211,000 Please note that zones may be updated as market data changes but we will honor the range applicable to your zone (which is determined by your location) as of your application date